COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte Donors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02796105
Recruitment Status : Completed
First Posted : June 10, 2016
Last Update Posted : September 13, 2017
Information provided by (Responsible Party):
Fundació Privada Eugin

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2017
Actual Study Completion Date : July 10, 2017